Search
for
Sort by
Research 30 of 445
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Alopecia areata after dupilumab for atopic dermatitis
- Dupilumab: A Review of Present Indications and Off-Label Uses
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Drug-induced alopecia after dupilumab therapy
- Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Dupilumab and alopecia: A Janus effect
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Dupilumab side effect in a patient with atopic dermatitis: a case report study
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Dupilumab‐induced psoriasis in a patient with atopic dermatitis and alopecia totalis: A case report and literature review
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
- Dupliumab therapy for alopecia areata: a case series and review of the literature
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis
- The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
- Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Dupilumab in a 9-week-old with Netherton Syndrome Leads to Deep Symptom Control
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- 735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD
- Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
- Drug-induced subacute cutaneous lupus erythematosus secondary to Dupilumab: A case report
- Dupilumab for a 5‐year‐old child with prurigo nodularis